HYDROmorphone HCl 10mg/ in 0 recalled over sterility concerns
- Recall date
- December 17, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SCA Pharmaceuticals recalls HYDROmorphone HCl 10mg/50mL in 0.9% Sodium Chloride Injection, CII, Rx Only, 50 mL Single Dose Syringe, SCA Pharmaceuti…
- Recall number
- D-0215-2021
- FDA classification
- Class II
- Brand / firm
- SCA Pharmaceuticals
- Sold / distributed
- Product was distributed to hospitals nationwide.
Why it was recalled
Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
HYDROmorphone HCl 10mg/50mL in 0.9% Sodium Chloride Injection, CII, Rx Only, 50 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004030022
Get recall alerts
Free email alert whenever SCA Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SCA Pharmaceuticals